格隆汇3月28日丨金活医药集团(01110.HK)发布公告,截至2024年12月31日止年度,收益达到人民币10.61亿元,公司拥有人应占溢利增加9.1%至约人民币4155.7万元,每股基本盈利约人民币7.22分,拟派发末期股息每股3.17港仙。回顾年度内,来自药品分销分部销售额录得销售额约人民币7.50亿元,按年增长2.0%,品牌影响力持续提升。其中,集团主力代理药品京都念慈庵川贝枇杷膏表现符合...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.